4983614 Benzhydryloxyethyl piperidine derivatives, process for their preparation and pharmaceutical compositions, in which they are present

4983614 Benzhydryloxyethyl piperidine derivatives, process for their preparation and pharmaceutical compositions, in which they are present

xx New Patents 4983614 BENZHYDRYLOXYETHYL PIPERIDINE DERIVATIVES, P R O C E S S FOR THEIR PREPARATION AND PHARMACEUTICAL C O M P O S I T I O N S , I...

67KB Sizes 27 Downloads 94 Views

xx

New Patents

4983614 BENZHYDRYLOXYETHYL PIPERIDINE DERIVATIVES, P R O C E S S FOR THEIR PREPARATION AND PHARMACEUTICAL C O M P O S I T I O N S , IN WHICH THEY ARE P R E S E N T Andre Merour Jean-Yves Buzas, Roland O1livier, Bievres, France assigned to Les Laboratoires M e r a m The invention relates to benzhydryloxyethylpiperidine derivatives corresponding to one of the formulae below: See Patent for Chemical Structure (I) R 1 R 2 C R 3 R 4 H O C H 2 C H 2 N C H C O O R (II) in which: R I , R2, R3 and R4, which are identical or different, represent a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an aryloxy group or the trifluoromethyl group, R represents hydrogen, a cation, an alkyl group, an aryl group or an arylalkyl group, and n is equal to 0 or 1, and their pharmaceutically acceptable salts, useful in the treatment of spasmodic states and allergies.

for Chemical Structure R1 and R2 are each hydrogen or C1-6 alkyl, R3, R4, R5 and R6 are each hydrogen, hydroxy, halogen, nitro, cyano, carboxy, C1-4 alkyl, C1-4 alkoxy, C l - 4 alkylthio, halo-substituted C1-4 alkyl, halosubstituted C1-4 alkoxy, halo-substituted C1-4 alkylthio, C2-5 alkoxycarbonyl, optionally substituted phenyl, optionally substituted phenoxy, R ' R " N - where R' and R " are each hydrogen or C1-4 alkyl or R ' " C O N H - where R ' " is C1-4 alkyl, or a group of the formula -CR7R8R9 in which R7, R8 and R9 are each C1-6 alkyl, halosubstituted C1-6 alkyl or optionally substituted phenyl, or R7 and R8, together with the carbon atom to which they are attached, form a cycloalkyl group containing 3 to 7 carbon atoms, or R7, R8 and R9 together with the carbon atom to which they are attached, form a bicycloalkyl group containing 4 to 9 carbon atoms, and Y is a 5- or 6-membered heterocyclic ring excluding pyrazole; and salts thereof.

4983632

PHARMACEUTICAL COMPOUNDS

USE OF G A M M A H Y D R O X Y B U T Y R I C ACID SALTS FOR P R E P A R I N G PHARMACEUTICAL C O M P O S I T I O N S FOR U S E IN THE T R E A T M E N T OF A L C O H O L I S M , AND THE C O M P O S I T I O N S OBTAINED

Peter T Gallagher, Terence Hicks, Yateley, United Kingdom assigned to Lilly Industries Limited

Gian Luigi Gessa, Fabio Fadda, di Campochiaro Chiara Mormile, Cagliari, Italy assigned to Laboratorio Farmaceutico C T S r 1

C o m p o u n d s of the following formula have pharmaceutical properties: See Patent for Chemical Structure in which X is R ' ( H O ) C double bondC(CN)-, R I ( C O ) - C H ( C N ) - or See Patent

The use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions useful for the release form ethyl alcohol consumption and the compostions obtained.

4983619

For i n f o r m a t i o n about P A T S E A R C H

Pergamon Orbit InfoLine Inc. 8000 Westpark Drive McLean, VA 22102 USA Telephone (703) 442-0900 Telex: 09-1811

~

Pergamon Orbit InfoLine Ltd 12 Vandy Street London EC2A 2DE UK Telephone (071) 377-4650 Telex: 8814614